M&A

M&A

Duff & Phelps : Sailing Through Complexity when Consulting

by

With more than 7,500 cases performed in 2014 and around 3,000 clients, the independent financial advisor has become the darling of BoDs, private equity and law firms. Now ranking 3rd in global fairness opinion providers and U.S. middle market M&A advisory, Duff & Phelps tops the charts for delivering tailored models as a relevant positioning in valuation and corporate advisory. We tried to understand how the firm has converted its specific corporate culture into a powerful selling point.

Global Biotech Industry

by

The worldwide biotechnology industry came to new statures in 2014, setting records on essentially every major money related metric, including incomes, productivity and capital raised. These positive execution markers, joined with a few prominent item victories and an in number year for new medication supports, drove the business’ aggregate business underwriting over the US$1t edge without precedent for its history. These and different discoveries were discharged on June 15 in Beyond fringes: Reaching new statures, EY’s 29th yearly biotechnology industry report.